Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study:Uptake, Outcome, and Risk Factors for Treatment Failures
RecruitingNCT06405464
University of ZurichHIV Infections
Start: 2022-03-01End: 2026-06-30Target: 600Updated: 2024-05-08